Skip to main navigation Skip to search Skip to main content

Identifying the Optimal Number of Neoadjuvant Chemotherapy Cycles in Patients with Muscle-Invasive Bladder Cancer

  • David D'Andrea
  • , Peter C. Black
  • , Homayoun Zargar
  • , C. P. Dinney
  • , Francesco Soria
  • , M. S. Cookson
  • , Jeffrey S Montgomery
  • , Wassim Kassouf
  • , Marc A Dall'Era
  • , Srikala S. Sridhar
  • , John S McGrath
  • , Jonathan Wright
  • , Andrew C. Thorpe
  • , J. M. Holzbeierlein
  • , Diego Carrión
  • , Ettore Di Trapani
  • , Trinity J Bivalacqua
  • , Scott North
  • , Daniel A Barocas
  • , Yair Lotan
    • Petros Grivas, Andrew J Stephenson, Bas W van Rhijn, Siamak Daneshmand, Philippe E Spiess, Shahrokh F Shariat, Kamran Zargar-Shoshtari, Laura S Mertens, Adrian S Fairey, Maria C Mir, Laura-Maria Krabbe, Niels-Erik Jacobsen, Nikhil Vasdev, Evan Y Yu, Evanguelos Xylinas, Benjamin Pradere, Renate Pichler, Nicholas J Campain, J. A. Seah, C. E. Ercole, Simon Horenblas, J. Aning, Todd M Morgan, Jay B Shah, Marco Moschini

Research output: Contribution to journal › Article › peer-review

28 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Identifying the Optimal Number of Neoadjuvant Chemotherapy Cycles in Patients with Muscle-Invasive Bladder Cancer'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Nursing and Health Professions

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology